What is Intellia Therapeutics's EV / sales?

Intellia Therapeutics (NTLA) reported EV / sales of 22.1× in Q1 2026.

How has Intellia Therapeutics's EV / sales changed year-over-year?

Intellia Therapeutics's EV / sales increased by 38.2% year-over-year, from 16× to 22.1×.

What is the long-term trend for Intellia Therapeutics's EV / sales?

Over 5 years (2020 to 2025), Intellia Therapeutics's EV / sales has grown at a -26.6% compound annual growth rate (CAGR), from 67.7× to 14.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Intellia Therapeutics NTLA EV / sales

EV / sales at other companies

Ionis PharmaceuticalsIONS

12.2×+5.7×

ALN

Alnylam PharmaceuticalsALNY

9.9×-4.7×

CRISPR TherapeuticsCRSP

1,201.6×+1,125×

Beam TherapeuticsBEAM

14.6×-10.3×

Krystal Biotech, Inc.KRYS

16.9×+2.2×

Relay Therapeutics, Inc.RLAY

150.4×+98.6×

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.13B+106%

Enterprise value$2.08B+100%

P/S32.2×+9.5×

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Calculated from Intellia Therapeutics’s reported figures.

enterprise value/total revenue=22.1×

Based on the most recent quarter.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's EV / sales?: Intellia Therapeutics (NTLA) reported EV / sales of 22.1× in Q1 2026.
How has Intellia Therapeutics's EV / sales changed year-over-year?: Intellia Therapeutics's EV / sales increased by 38.2% year-over-year, from 16× to 22.1×.
What is the long-term trend for Intellia Therapeutics's EV / sales?: Over 5 years (2020 to 2025), Intellia Therapeutics's EV / sales has grown at a -26.6% compound annual growth rate (CAGR), from 67.7× to 14.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.